The latest report by IMARC Group, titled “Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on the global cardiac biomarkers market research report. The report also includes competitor and regional analysis, and contemporary advancements in the market.

The global cardiac biomarkers market size reached US$ 9.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.42% during 2023-2028.

Global Cardiac Biomarkers Market Overview:

Cardiac biomarkers are specific molecules or substances that are released into the bloodstream in response to various heart-related conditions and events. These biomarkers are used to assess and diagnose cardiac diseases and injuries, as well as to monitor the progression and effectiveness of treatments. They play a critical role in modern medical practice by providing valuable insights into the health and functioning of the heart. Some commonly used cardiac biomarkers include troponins, creatine kinase (CK), and B-type natriuretic peptide (BNP).

Troponins are proteins released into the blood when there is damage to the heart muscle, such as during a heart attack. Elevated troponin levels in the blood indicate myocardial injury and are crucial for diagnosing acute coronary syndromes. Creatine kinase, specifically the MB isoenzyme (CK-MB), is another biomarker that rises when there’s damage to heart tissue. However, its use has decreased with the widespread adoption of troponin testing.

Get a Sample Copy of the Report at: https://www.imarcgroup.com/cardiac-biomarkers-market/requestsample

Global Cardiac Biomarkers Market Trends:

The increasing prevalence of cardiovascular diseases (CVDs) and the growing importance of early disease detection and management is driving the global market. The rising global burden of CVDs, including heart attacks, congestive heart failure, and arrhythmias, has led to a higher demand for accurate diagnostic tools. Cardiac biomarkers offer a non-invasive and effective means of diagnosing and monitoring these conditions, which has significantly contributed to the market’s expansion.

However, continual advancements in medical technology have led to the development of sensitive and specific assays that can detect even minor changes in cardiac biomarker levels. This has facilitated early diagnosis and risk stratification, enabling healthcare professionals to provide timely interventions and personalized treatment plans. Additionally, the growing awareness among individuals about the importance of heart health and routine check-ups has resulted in higher screening rates, further boosting the market.

Explore the Full Report with Charts, Table of Contents, and List of Figures:https://www.imarcgroup.com/cardiac-biomarkers-market

Competitive Landscape with Key Players:

The competitive landscape of the market has also been analyzed, with some of the key players operating in the market being

  • Abbott Laboratories
  • Alere Inc.
  • Beckman Coulter
  • Becton
  • Dickinson And Co.
  • Biomerieux
  • Bio-Rad Laboratories
  • Randox Laboratories
  • Roche Diagnostics Corporation
  • Siemens Healthcare
  • Thermo Fisher Scientific.

Breakup by Type:

  • Troponins (T and I)
  • Myocardial Muscle Creatine Kinase (CK-MB)
  • Myoglobin
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP
  • Ischemia Modified Albumin (IMA)
  • Others

Breakup by Location of Testing:

  • Laboratory Testing
  • Point of Care Testing

Breakup by Application:

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

  • Market Performance 
  • Market Outlook 
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800